The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 13, 2025

Filed:

Mar. 28, 2019
Applicant:

Epicentrx, Inc., La Jolla, CA (US);

Inventors:

Christopher Larson, San Diego, CA (US);

Bryan T. Oronsky, Los Altos Hills, CA (US);

Tony R. Reid, San Diego, CA (US);

Assignee:

EPICENTRX, INC., La Jolla, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/761 (2015.01); A61K 38/16 (2006.01); C12N 15/10 (2006.01); C12N 15/861 (2006.01);
U.S. Cl.
CPC ...
A61K 35/761 (2013.01); A61K 38/16 (2013.01); C12N 15/102 (2013.01); C12N 15/861 (2013.01);
Abstract

The invention provides for a recombinant adenoviral vector comprising a recombinant oncolytic adenovirus which has: (1) a modified transcription regulatory sequence wherein the adenoviral vector is transcriptionally active in cancer cells and/or hyperproliferative cells and transcriptionally attenuated in normal cells, and (2) a transgene encoding one or more cancer antigens that are specific to a subject. The invention further provides a method of producing said recombinant adenoviral vector. The recombinant oncolytic adenoviral vector described above is used in methods of stimulating a heightened immune response against a cancer antigen in a subject or a method of treating cancer in a subject.


Find Patent Forward Citations

Loading…